Buffy's, B cells, and membrane BAFF

Arthritis and Rheumatism

Volumn 62, Issue 5, 2010, Pages 1557-1558

  Schneider, Pascal ^a   Huard, Bertrand ^b  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

^b GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

APRIL PROTEIN; B CELL ACTIVATING FACTOR; PROTEIN BCL 2; PROTEIN BUFFY 1; PROTEIN BUFFY 2; UNCLASSIFIED DRUG;

B LYMPHOCYTE; CARBOXY TERMINAL SEQUENCE; CELL MEMBRANE; CELL SURFACE; FLOW CYTOMETRY; LETTER; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN SECRETION;

ANTIBODIES, MONOCLONAL; B-CELL ACTIVATING FACTOR; B-LYMPHOCYTES; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC;

EID: 77951734491     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.27360     Document Type: Letter

References (5)

1. Chu VT, Enghard P, Schurer S, Steinhauser G, Rudolph B, Riemekasten G, et al. Systemic activation of the immune system induces aberrant BAFF and APRIL expression in B cells in patients with systemic lupus erythematosus. Arthritis Rheum 2009;60:2083-2093
2. Chu VT, Enghard P, Riemekasten G, Berek C. In vitro and in vivo activation induces BAFF and APRIL expression in B cells. J Immunol 2007;179:5947-5957
3. Schneider P, MacKay F, Steiner V, Hofmann K, Bodmer JL, Holler N, et al. BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth. J Exp Med 1999;189:1747-1756 (Pubitemid 29272691)
4. Carter RH, Zhao H, Liu X, Pelletier M, Chatham W, Kimberly R, et al. Expression and occupancy of BAFF-R on B cells in systemic lupus erythematosus. Arthritis Rheum 2005;52:3943-3954 (Pubitemid 41798234)
5. Schwaller J, Schneider P, Mhawech-Fauceglia P, McKee T, Myit S, Matthes T, et al. Neutrophil-derived APRIL concentrated in tumor lesions by proteoglycans correlates with human B-cell lymphoma aggressiveness. Blood 2007;109:331-338 (Pubitemid 46053074)